OPKO Health, Inc. Deconsolidation, Gain (Loss), Amount
OPKO Health, Inc. (OPK) reported Deconsolidation, Gain (Loss), Amount of $0 for the 12-month period ending 2017-12-31, per its 8-K filed 2019-01-29.
Discontinued › Income Statement › Other Income
us-gaap:DeconsolidationGainOrLossAmount · last filed 2019-01-29
- OPKO Health, Inc. deconsolidation, gain (loss), amount for the quarter ending 2016-12-31 was $0.00.
- OPKO Health, Inc. deconsolidation, gain (loss), amount for the quarter ending 2015-12-31 was -$1.40M.
- OPKO Health, Inc. deconsolidation, gain (loss), amount for the quarter ending 2014-12-31 was $0.00.
- OPKO Health, Inc. deconsolidation, gain (loss), amount for fiscal 2014 was $0.00.
- OPKO Health, Inc. deconsolidation, gain (loss), amount for fiscal 2013 was $0.00.
| Period end | Deconsolidation, Gain (Loss), Amount 3 month | Deconsolidation, Gain (Loss), Amount 9 month | Deconsolidation, Gain (Loss), Amount 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 8-K · filed 2019-01-29 | ||
| 2016-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $0.00 8-K · filed 2019-01-29 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 | ||
| 2015-12-31 | -$1.40M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $15.94M 8-K · filed 2019-01-29 | |
| 2015-09-30 | $17.34M 10-Q · filed 2016-11-07 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-09 | ||
| 2013-12-31 | $0.00 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |